Adaptive trial designs: a review of barriers and opportunities
Open Access
- 23 August 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Trials
- Vol. 13 (1), 145
- https://doi.org/10.1186/1745-6215-13-145
Abstract
Adaptive designs allow planned modifications based on data accumulating within a study. The promise of greater flexibility and efficiency stimulates increasing interest in adaptive designs from clinical, academic, and regulatory parties. When adaptive designs are used properly, efficiencies can include a smaller sample size, a more efficient treatment development process, and an increased chance of correctly answering the clinical question of interest. However, improper adaptations can lead to biased studies. A broad definition of adaptive designs allows for countless variations, which creates confusion as to the statistical validity and practical feasibility of many designs. Determining properties of a particular adaptive design requires careful consideration of the scientific context and statistical assumptions. We first review several adaptive designs that garner the most current interest. We focus on the design principles and research issues that lead to particular designs being appealing or unappealing in particular applications. We separately discuss exploratory and confirmatory stage designs in order to account for the differences in regulatory concerns. We include adaptive seamless designs, which combine stages in a unified approach. We also highlight a number of applied areas, such as comparative effectiveness research, that would benefit from the use of adaptive designs. Finally, we describe a number of current barriers and provide initial suggestions for overcoming them in order to promote wider use of appropriate adaptive designs. Given the breadth of the coverage all mathematical and most implementation details are omitted for the sake of brevity. However, the interested reader will find that we provide current references to focused reviews and original theoretical sources which lead to details of the current state of the art in theory and practice.Keywords
This publication has 70 references indexed in Scilit:
- Are Titania Photocatalysts and Titanium Implants Safe? Review on the Toxicity of Titanium CompoundsNanomaterials, 2020
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerThe New England Journal of Medicine, 2011
- A Bayesian response‐adaptive covariate‐balanced randomization design with application to a leukemia clinical trialStatistics in Medicine, 2011
- Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation designInvestigational New Drugs, 2011
- Combining an Internal Pilot with an Interim Analysis for Single Degree of Freedom TestsCommunications in Statistics - Theory and Methods, 2010
- Internal pilots for observational studiesBiometrical Journal, 2010
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase IIIAnnals of Neurology, 2009
- Sample size re‐estimation in clinical trialsBiometrical Journal, 2009
- Adaptive designs for confirmatory clinical trialsStatistics in Medicine, 2009
- The design of simulation studies in medical statisticsStatistics in Medicine, 2006